cloudfront

Report Detail



Pharma & HealthcareGlobal Propofol Market Insights, Forecast to 2025

  • RnM2316489
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Propofol Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Propofol Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Propofol Market Size Growth Rate by Type
      • 1.4.2 Power
      • 1.4.3 Liquid
    • 1.5 Market by Application
      • 1.5.1 Global Propofol Market Size Growth Rate by Application
      • 1.5.2 Medical Uses
      • 1.5.3 Other Uses
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Propofol Market Size
      • 2.1.1 Global Propofol Revenue 2016-2025
      • 2.1.2 Global Propofol Sales 2016-2025
    • 2.2 Propofol Growth Rate by Regions
      • 2.2.1 Global Propofol Sales by Regions
      • 2.2.2 Global Propofol Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Propofol Sales by Manufacturers
      • 3.1.1 Propofol Sales by Manufacturers
      • 3.1.2 Propofol Sales Market Share by Manufacturers
      • 3.1.3 Global Propofol Market Concentration Ratio (CR5 and HHI)
    • 3.2 Propofol Revenue by Manufacturers
      • 3.2.1 Propofol Revenue by Manufacturers (2016-2018)
      • 3.2.2 Propofol Revenue Share by Manufacturers (2016-2018)
    • 3.3 Propofol Price by Manufacturers
    • 3.4 Propofol Manufacturing Base Distribution, Product Types
      • 3.4.1 Propofol Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Propofol Product Category
      • 3.4.3 Date of International Manufacturers Enter into Propofol Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Propofol Sales by Type
    • 4.2 Global Propofol Revenue by Type
    • 4.3 Propofol Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Propofol Breakdown Data by Application

    6 North America

    • 6.1 North America Propofol by Countries
      • 6.1.1 North America Propofol Sales by Countries
      • 6.1.2 North America Propofol Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Propofol by Type
    • 6.3 North America Propofol by Application
    • 6.4 North America Propofol by Company

    7 Europe

    • 7.1 Europe Propofol by Countries
      • 7.1.1 Europe Propofol Sales by Countries
      • 7.1.2 Europe Propofol Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Propofol by Type
    • 7.3 Europe Propofol by Application
    • 7.4 Europe Propofol by Company

    8 Asia Pacific

    • 8.1 Asia Pacific Propofol by Countries
      • 8.1.1 Asia Pacific Propofol Sales by Countries
      • 8.1.2 Asia Pacific Propofol Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Propofol by Type
    • 8.3 Asia Pacific Propofol by Application
    • 8.4 Asia Pacific Propofol by Company

    9 Central & South America

    • 9.1 Central & South America Propofol by Countries
      • 9.1.1 Central & South America Propofol Sales by Countries
      • 9.1.2 Central & South America Propofol Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Propofol by Type
    • 9.3 Central & South America Propofol by Application
    • 9.4 Central & South America Propofol by Company

    10 Middle East and Africa

    • 10.1 Middle East and Africa Propofol by Countries
      • 10.1.1 Middle East and Africa Propofol Sales by Countries
      • 10.1.2 Middle East and Africa Propofol Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Propofol by Type
    • 10.3 Middle East and Africa Propofol by Application
    • 10.4 Middle East and Africa Propofol by Company

    11 Company Profiles

    • 11.1 AstraZeneca
      • 11.1.1 AstraZeneca Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Propofol
      • 11.1.4 Propofol Product Description
      • 11.1.5 Recent Development
    • 11.2 Fresenius Kabi
      • 11.2.1 Fresenius Kabi Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Propofol
      • 11.2.4 Propofol Product Description
      • 11.2.5 Recent Development
    • 11.3 B.Braun Melsungen
      • 11.3.1 B.Braun Melsungen Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Propofol
      • 11.3.4 Propofol Product Description
      • 11.3.5 Recent Development
    • 11.4 Hospira
      • 11.4.1 Hospira Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Propofol
      • 11.4.4 Propofol Product Description
      • 11.4.5 Recent Development
    • 11.5 Xi'an Libang
      • 11.5.1 Xi'an Libang Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Propofol
      • 11.5.4 Propofol Product Description
      • 11.5.5 Recent Development
    • 11.6 Sichuan Guorui
      • 11.6.1 Sichuan Guorui Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Propofol
      • 11.6.4 Propofol Product Description
      • 11.6.5 Recent Development
    • 11.7 Guangdong Jiabo
      • 11.7.1 Guangdong Jiabo Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Propofol
      • 11.7.4 Propofol Product Description
      • 11.7.5 Recent Development
    • 11.8 Jiangsu Nhwa
      • 11.8.1 Jiangsu Nhwa Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Propofol
      • 11.8.4 Propofol Product Description
      • 11.8.5 Recent Development
    • 11.9 Piramal Critical
      • 11.9.1 Piramal Critical Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Propofol
      • 11.9.4 Propofol Product Description
      • 11.9.5 Recent Development
    • 11.10 Bachem
      • 11.10.1 Bachem Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Propofol
      • 11.10.4 Propofol Product Description
      • 11.10.5 Recent Development

    12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators

    13 Value Chain and Sales Channels Analysis

    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Propofol Raw Material
      • 13.1.2 Propofol Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Author Details

      This report studies the global market size of Propofol in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Propofol in these regions.
      This research report categorizes the global Propofol market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

      In 2017, the global Propofol market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Propofol market based on company, product type, application and key regions.

      The various contributors involved in the value chain of Propofol include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Propofol include
      AstraZeneca
      Fresenius Kabi
      B.Braun Melsungen
      Hospira
      Xi'an Libang
      Sichuan Guorui
      Guangdong Jiabo
      Jiangsu Nhwa
      Piramal Critical
      Bachem

      Market Size Split by Type
      Power
      Liquid
      Market Size Split by Application
      Medical Uses
      Other Uses

      Market size split by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Propofol market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Propofol market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Propofol manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Propofol with respect to individual growth trends, future prospects, and their contribution to the total market.
      To project the value and volume of Propofol submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      In this study, the years considered to estimate the market size of Propofol are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Propofol market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Propofol. Industry analysis & Market Report on Propofol is a syndicated market report, published as Global Propofol Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Propofol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      2,618.85
      5,237.70
      3,588.78
      7,177.56
      472,446.00
      944,892.00
      258,622.26
      517,244.52
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report